PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Mar 2022 07:00

RNS Number : 6733F
ReNeuron Group plc
23 March 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BF5G6K95

Issuer Name

RENEURON GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

21-Mar-2022

6. Date on which Issuer notified

22-Mar-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.734800

0.268700

1.003500

572650

Position of previous notification (if applicable)

0.734800

3.035000

3.769800

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BF5G6K95

419300

0.734800

Sub Total 8.A

419300

0.734800%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

153350

0.268700

Sub Total 8.B1

153350

0.268700%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Alex Longmuir01727895161

12. Date of Completion

22-Mar-2022

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEANDAADFAEFA
Date   Source Headline
18th Dec 20204:36 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSNotification of Major Holdings
17th Dec 202012:44 pmRNSNotification of Major Holdings
17th Dec 20207:00 amRNSNotification of Major Holdings
17th Dec 20207:00 amRNSNotification of Allowance granted for US Patent
16th Dec 20205:37 pmRNSNotification of Major Holdings
16th Dec 20202:17 pmRNSNotification of Major Holdings
16th Dec 20207:00 amRNSNotification of Major Holdings
11th Dec 202010:33 amRNSResult of General Meeting and Total Voting Rights
11th Dec 20207:00 amRNSResult of Open Offer
25th Nov 20204:41 pmRNSSecond Price Monitoring Extn
25th Nov 20204:36 pmRNSPrice Monitoring Extension
25th Nov 20202:06 pmRNSSecond Price Monitoring Extn
25th Nov 20202:00 pmRNSPrice Monitoring Extension
25th Nov 202011:05 amRNSSecond Price Monitoring Extn
25th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension
24th Nov 20202:06 pmRNSSecond Price Monitoring Extn
24th Nov 20202:00 pmRNSPrice Monitoring Extension
24th Nov 20207:15 amRNSResult of Placing and Subscription and GM Notice
24th Nov 20207:00 amRNSInterim Results
23rd Nov 20205:42 pmRNSProposed Placing, Subscription and Open Offer
2nd Nov 20207:00 amRNSTotal Voting Rights
10th Sep 20203:59 pmRNSResult of AGM
10th Sep 20207:00 amRNSAGM Trading Update
1st Sep 20207:00 amRNSBlock Listing Review and Total Voting Rights
18th Aug 20207:00 amRNSPosting of Annual Report and Notice of AGM
12th Aug 20207:00 amRNSChanges to Non-Executive Board
3rd Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20207:00 amRNSNotification of Allowance granted for US Patent
20th Jul 20207:00 amRNSPreliminary Results
14th Jul 20203:06 pmRNSNotification of Major Holdings
29th Jun 20207:00 amRNSFurther Positive Data in Retinal Clinical Trial
25th Jun 20207:00 amRNSNew Exosome Research Collaboration
17th Jun 20207:00 amRNSRegulatory Approvals and Programme Update
7th May 20207:00 amRNSCTX cell line shows further potential
7th Apr 20202:06 pmRNSSecond Price Monitoring Extn
7th Apr 20202:00 pmRNSPrice Monitoring Extension
7th Apr 202011:06 amRNSSecond Price Monitoring Extn
7th Apr 202011:00 amRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSExosome Research Collaboration
3rd Apr 20207:00 amRNSCOVID-19 Update
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:39 pmRNSPrice Monitoring Extension
2nd Mar 20207:00 amRNSBlock Listing Review and Total Voting Rights
24th Feb 20207:00 amRNSPositive long-term data in retinal clinical trial
17th Feb 20207:00 amRNSPositive Phase 2a stroke clinical data published
12th Feb 20207:02 amRNSNotification of Major Holdings
12th Feb 20207:01 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.